Physician profile
Ronak J Patel
NPI 1366704280
$1,616.03
in general payments reported to CMS, 2019-2025
12 companies · $127 in 2025
The $127 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $323 · 2021: $178 · 2022: $110 · 2023: $105 · 2024: $476 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684 · Gift: $23.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.96 |
| Gift | $23.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $839.66 | 2019-2024 | |
| Glaukos Corporation | $275.00 | 2024-2025 | Ce-Marked Kxla System, Photrexa Viscous and Photrexa, Idose |
| Harrow Eye, LLC | $185.55 | 2024 | |
| Biohorizons Implant Systems INC. | $78.55 | 2022 | |
| Salvin Dental Specialties, INC. | $61.63 | 2021 | |
| Zimmer Biomet Holdings, INC. | $42.23 | 2021 | |
| Ucb, INC. | $33.99 | 2025 | Bimzelx |
| Align Technology, INC. | $32.39 | 2019-2024 | Invisalign |
| Astellas Pharma US INC | $23.23 | 2025 | Izervay |
| Kerr Corporation | $20.40 | 2022 | |
| Kulzer, LLC | $11.90 | 2019 | |
| Ultradent Products INC | $11.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronak Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.